Evans, T. (2009, January 6). Bevacizumab: the first FDA-approved angiogenesis inhibitor in the treatment of non-small cell lung cancer [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved July 16, 2020, from https://hstalks.com/bs/1113/.
Published on January 6, 2009
Dr. Tracey Evans has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.